Table 3.

Moderators of body composition response to exercise training in lymphoma patients

Baseline M (SD)Posttest M (SD)Adjusted M change M (95% CI)Adjusted subgroup difference in M change: M (95% CI); PAdjusted interaction effect M (95% CI); P
Disease stage on lean body mass, kg
ND
    UC52.1 (9.8)51.8 (9.5)0.6 (−0.2 to 1.5)0.0 (−1.1 to 1.2); 0.96SI/II vs ND
    AET50.6 (11.0)50.4 (11.3)0.7 (−0.2 to 1.5)0.4 (−1.2 to 2.0); 0.61
SI/II
    UC48.1 (9.8)48.4 (10.1)0.2 (−0.5 to 0.9)0.4 (−0.6 to 1.5); 0.43SIII/IV vs SI/II
    AET55.0 (11.6)55.1 (12.2)0.6 (−0.2 to 1.4)1.4 (−0.1 to 2.8); 0.070
SIII/IV
    UC49.9 (10.4)49.7 (10.5)−0.5 (−1.3 to 0.2)1.8 (0.8 to 2.8); 0.001SIII/IV vs ND
    AET51.5 (10.3)51.2 (11.0)1.2 (0.5 to 2.0)1.8 (0.2 to 3.3); 0.025
Baseline general health on body fat, %
P/F
    UC31.7 (7.7)33.9 (6.4)0.1 (−1.9 to 2.1)−0.4 (−2.8 to 2.1); 0.76GD vs P/F
    AET38.0 (7.6)38.2 (8.2)−0.3 (−1.7 to 1.1)−1.8 (1.0 to −4.6); 0.19
GD
    UC33.9 (11.2)35.3 (10.6)1.4 (0.4 to 2.4)−2.2 (−0.8 to −3.6); 0.002GD vs VG/EX
    AET33.3 (11.9)32.9 (12.0)−0.8 (−1.7 to 0.1)−2.5 (−0.5 to −4.4); 0.012
VG/EX
    UC32.0 (11.5)31.8 (11.0)0.3 (−0.5 to 1.0)0.3 (−1.0 to 1.6); 0.67P/F vs VG/EX
    AET28.8 (6.5)29.4 (6.6)0.5 (−0.5 to 1.6)−0.6 (2.2 to −3.5); 0.64

NOTE: Mean (SD) at posttest are based on available data (n = 111). Adjusted mean change, adjusted subgroup difference in mean change, and adjusted interaction effect are estimated based on mixed model analysis adjusted for baseline value of the outcome, age, sex, disease stage, major disease type, current treatment status, and recent exercise (a covariate was excluded if tested as a moderator).

Abbreviation: ND, no disease.